Related Experiment Video
Updated: Jun 16, 2025

Remote Laboratory Management: Respiratory Virus Diagnostics
Published on: April 6, 2019
Control measures for neglected tropical diseases: vaccine updates.
Vivek P Chavda1, Suneetha Vuppu2, Toshika Mishra2
1Department of Pharmaceutics and Pharmaceutical Technology, LM College of Pharmacy, Ahmedabad, India.
Neglected tropical diseases (NTDs) pose a significant global health threat, especially in low-income tropical regions. Developing effective vaccines for these diverse diseases presents challenges, but technological advancements offer new possibilities for personalized treatments.
Area of Science:
- Tropical medicine
- Infectious disease epidemiology
- Vaccinology
Background:
- Neglected tropical diseases (NTDs) are a growing public health concern, disproportionately affecting low-income populations in tropical areas.
- NTDs encompass a range of bacterial, viral, and parasitic infections, with some, like leishmaniasis and schistosomiasis, causing high mortality rates.
- The World Health Organization (WHO) prioritized 20 NTDs in 2020, underscoring the urgent need for global action.
Purpose of the Study:
- To discuss the etiology, types, and management strategies for NTDs, with a focus on vaccination.
- To review the limitations of current NTD vaccines and explore the potential for developing novel formulations.
- To highlight the challenges and opportunities in NTD vaccine development.
Main Methods:
- Literature review of NTD etiology, epidemiology, and vaccine development.
- Analysis of current vaccine limitations and research resource constraints.
- Exploration of technological advancements in vaccine design.
Main Results:
- Vaccine development for NTDs is hindered by disease complexity, insufficient research funding, and limited pharmaceutical industry engagement.
- Existing vaccine technologies face challenges in addressing the wide spectrum of NTD pathogens.
- Technological progress is paving the way for potentially personalized vaccines targeting specific NTD vulnerabilities.
Conclusions:
- Collaborative efforts are crucial to combat the detrimental impact of NTDs.
- Overcoming challenges in NTD vaccine development requires innovation and investment.
- Personalized vaccine approaches may offer a future strategy for controlling NTDs.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Transmission-based Precautions I: Contact, Enteric, and Droplets
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Vaccinations
Standard Precaution
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...

